期刊文献+

罗库溴胺用于重症肌无力患者胸腺切除术的肌松效应 被引量:4

Neuromuscular pharmacodynamics of rocumnium bromide in thymectomy of myasthenia gravis patients
在线阅读 下载PDF
导出
摘要 目的:探讨罗库溴铵在重症肌无力(MG)患者胸腺切除术中的肌松效应。方法:选择本院择期拟行胸腺切除术Ⅰ~Ⅱa型MG患者23例为试验组,20例正常非MG患者为对照组,均采用气管插管全凭静脉麻醉,给予罗库溴铵0.6mg/kg诱导,术中使用肌松监测仪记录罗库溴铵神经肌肉阻滞效应,及应用多功能监测仪进行心率变异性分析。结果:所有患者麻醉平稳,手术顺利,未见不良反应发生。两组患者各时点平均动脉压(MAP)、HR、心率变异性(HRV)、低频/高频比(LF/HF)差异无统计学意义。试验组肌松起效时间短于对照组,两组之间差异有统计学意义(P<0.05)。两组肌松T125%恢复时间、T150%恢复时间、恢复指数差异均无统计学意义。结论:对Ⅰ~Ⅱa型MG患者使用0.6mg/kg罗库溴铵进行快速诱导行气管插管,肌松起效时间短,维持时间影响小,且不良反应少,可为气管插管提供良好的肌松条件,安全有效地用于MG患者。 AIM: To investigate the neuro- muscular pharmacodynamics of rocuronium on thymectomy in myasthenia gravis (MG) pa tients. METHODS: Twenty-three Ⅰ-Ⅱ a MG patients undergoing elective thymectomy (Group M) since January 2006 were studied. Another twenty non-MG patients undergoing other elec tive surgery were included as control group (Group C). All patients were performed under total intravenous anesthesia by tracheal intuba- tion, given a loading dose of rocuronium 0.6 mg/kg as anesthesia induction. Neuromuscular transmission was monitored by measuring the twitch tension of the adductor pollicis muscle. And the heart rate variability (HRV) was ana- lyzed during the surgery. RESULTS:Anesthesia and surgery were carried out successfully with- out any adverse reaction. The analysis revealed that the MAP, HR, HRV, LF/HF had no sig- nificant difference between the two groups at alltime points. The onset time was significantly shorter in group M than that in the group C (P 〈0.05). There were no significant group differ ences in the recovery time of T1 to 25%, the re covery time of T1 to 50%, and the recovery indi- ces (interval, 25% - 75%). CONCLUSION: The results show that rocuronium, as anesthesia induction at a dose of 0.6 mg/kg, has a shorter muscle relaxants onset time and a small influence on the maintaining time. It also can result in fe wer perioperative complications and provide op- timal operating conditions. It is a safe anaesthesi- a method in thymectomy of Ossermen Ⅰ-Ⅱ a MG patients with anesthesia induction by injec ting rocuronium.
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第11期1263-1267,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 安徽省卫生厅医学科研项目(2010C066)
关键词 雄甾烷醇类 重症肌无力 神经肌肉阻滞 心率变异性 Androstanol Myasthenia gra-vis Neuromuscular blockade Heart rate varia-bility
作者简介 鲁卫华,通信作者,男,硕士,主任医师,副教授,研究方向:围术期脏器功能维护。Tel:13955370637E-mail:1wh683@sohu.com
  • 相关文献

参考文献20

  • 1Ozdemir N, Kara M, Dikmen E. Predictors of clini- cal outcome following extended thymectomy in my- asthenia gravis [J]. Eur J Cardio-thoracic Surg, 2003,23(2) :233-237.
  • 2Della Rocca G, Coccia C, Diana L, et al. Propofol or sevoflurane anesthesia without muscle relaxants allow the early extubation o{ myasthenic patients[J]. CanJ Anaesth, 2003,50(6) :547-552.
  • 3石妤,左明章,闫春伶,孟小燕,杨宁.重症肌无力患者无肌松药下靶控输注丙泊酚时舒芬太尼诱导气管插管的半数有效浓度[J].临床麻醉学杂志,2008,24(2):143-144. 被引量:6
  • 4杜关贤,张昊.重症肌无力患者的麻醉选择探讨[J].海南医学,2006,17(7):6-8. 被引量:2
  • 5Puhringer FK,Gordon M, Demeyer I, et al. Sugam- madex rapidly reverses moderate rocuronium- or ve- curonium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relation- ship[J]. Br J Anaesth,2010,105(5) :610-619.
  • 6Hirsch NP. Neuromuscular junction in health and disease[J]. Br J Anaesth ,2007, 99(1) :132-138.
  • 7Stevens RD. Neuromuscular disorders and anesthe- sia[J]. Curt Opin Anaesthesiol, 2001,14(6) : 693- 698.
  • 8Cordero Escobar I. Rocuronium vs vecuronium for neuromuscular block during transsternal thymecto- my in the patient with myasthenia gravis[J]. Rev Esp Anestesiol Reanim, 2011,58 (10) : 578 - 582.
  • 9王洪萌,林财珠.围术期应激反应及其调控的若干问题[J].国际麻醉学与复苏杂志,2008,29(2):173-176. 被引量:11
  • 10张荃方,戚平平,王桂玲,赵晖.心率变异性的临床意义[J].实用心电学杂志,2006,15(6):422-422. 被引量:6

二级参考文献28

共引文献46

同被引文献33

  • 1乔庆,顾晓静,章岚,何非方,周大春.罗库溴铵和维库溴铵应用于气管插管的效果比较[J].浙江预防医学,2005,17(1):75-75. 被引量:4
  • 2应俊,吴敏,朱晓红,卢忆梅,陈受琳.罗库溴铵不同维持给药方法的药效动力学比较[J].实用临床医学(江西),2005,6(5):56-57. 被引量:3
  • 3Ozdemir N, Kara M, Dikmen E, et al. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiotho- rac Surg,2003,23(2) :233-237.
  • 4Jones RS. The use of neuromuscular blocking agents for thymeetomy in myasthenia gavis. Vet Anaesth Analg, 2012,39 (2) : 220.
  • 5hoh H, Shibata K, Nitta S. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth, 2001,87 (6) : 885-889.
  • 6Challan Belval A, Tramoni G, Vedrinne JM, et al. The use of sug- ammadex in a patient with myasthenia gravis. Ann Fr Anesth Re- anim, 2012, 31(6):569-570.
  • 7Duke-Novakovski T, Ambros B, Auckland CD, et al. The effects of succinylcholine or low-d0sc rocuronium to aid endotracheal intubation of adult sows. Can J Vet Res,2012,76(1) :57-61.
  • 8Kanaya N, Hirata N, Kurosawa S, et al. Differential effects of propofol and sevoflurane on heart rate variability. Anesthesiology, 2003,98(1) :34-40.
  • 9Olkkola KT, Tammisto T. Quantitation of the interaction of rocuroni- um bromide with etomidate, fentanyl, midazolam, propofol, thiopen- tone, and isoflurane using closed-loop feedback control of infusion of rocuronium. Eur J Anacsthesiol Suppl, 1994,9:99-100.
  • 10Pasutharnchat N, Wacharapluesadee S, Hemachudha T. Clinical ma- nifestations of acetylcholine receptor antibody positive and negative myasthenia gravis. J Med Assoe Thai, 2012,95(3):313-319.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部